CLNN · Company research
Clene Inc. Common Stock (CLNN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS | Clene Inc. (Nasdaq: CLNN) announced the submission of a New Drug Application (NDA) to the FDA in October 2026 seeking accelerated approval of CNM-Au8 for treating amyotrophic lateral sclerosis (ALS). The submission is based on neurofilament light chain biomarker data and clinical outcomes. The company plans to continue with a confirmatory Phase 3 RESTORE-ALS study while awaiting FDA review. | View source ↗ | GlobeNewswire Inc. | Oct 19, 2026 | bullish | 1 | 1 |
| Two parties report shared voting power over 221,660 shares in Clene (CLNN). - Stock Titan | Two parties report shared voting power over 221,660 shares in Clene (CLNN). Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Clene Inc. (CLNN) Slides 2.88% to $3.75 as Shares Approach Key Support - AAII Neutral - https://www.siam.in/ | Clene Inc. (CLNN) Slides 2.88% to $3.75 as Shares Approach Key Support - AAII Neutral https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 12, 2026 | neutral | 0 | 0.6 |
| Investors can meet Clene management in New York or online through Sept. 30 - Stock Titan | Investors can meet Clene management in New York or online through Sept. 30 Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| A $4 million raise is expected to carry an ALS biotech past a potential FDA decision - Stock Titan | A $4 million raise is expected to carry an ALS biotech past a potential FDA decision Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| Clene announces insider-led $4 million financing round - The Globe and Mail | Clene announces insider-led $4 million financing round The Globe and Mail | View source ↗ | The Globe and Mail | Sep 17, 2026 | neutral | 0 | 0.6 |
| Clene (NasdaqCM:CLNN) Stock Forecast & Analyst Predictions - Simply Wall Street | Clene (NasdaqCM:CLNN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Aug 18, 2026 | neutral | 0 | 0.6 |
| Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance | Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| $CLNN stock is down 14% today. Here's what we see in our data. - Quiver Quantitative | $CLNN stock is down 14% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| When Will Clene Inc. (NASDAQ:CLNN) Breakeven? - Simply Wall Street | When Will Clene Inc. (NASDAQ:CLNN) Breakeven? Simply Wall Street | View source ↗ | Simply Wall Street | Jul 21, 2026 | neutral | 0 | 0.6 |
| CLNN Forecast — Price Target — Prediction for 2027 - TradingView | CLNN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance | Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Yahoo Finance | View source ↗ | Yahoo Finance | Jun 4, 2026 | neutral | 0 | 0.6 |
| CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’ - Stocktwits | CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’ Stocktwits | View source ↗ | Stocktwits | May 14, 2026 | neutral | 0 | 0.6 |
| Clene stock tumbles after pricing $7M stock offering - Investing.com | Clene stock tumbles after pricing $7M stock offering Investing.com | View source ↗ | Investing.com | May 5, 2026 | neutral | 0 | 0.6 |
| CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - Stocktwits | CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment Stocktwits | View source ↗ | Stocktwits | May 4, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.